Biomarin Pharmaceutical Inc (BMRN) — Long-term Investment Intensity
Biomarin Pharmaceutical Inc (BMRN) has a Long-term Investment Intensity of 6.5% as of December 2025. Long-term investments of $492.24 Million represent 6.5% of total assets of $7.59 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Biomarin Pharmaceutical Inc liquidity resilience to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Biomarin Pharmaceutical Inc Long-term Investment Intensity (2010–2025)
This chart shows how Biomarin Pharmaceutical Inc's Long-term Investment Intensity has evolved across 16 annual periods from 2010 to 2025. As of December 2025, the intensity stands at 6.5%, reflecting long-term investments of $492.24 Million against total assets of $7.59 Billion USD. For the complete balance sheet picture, see BMRN total assets.
Annual Long-term Investment Intensity for Biomarin Pharmaceutical Inc (2010–2025)
The table below presents the year-by-year Long-term Investment Intensity for Biomarin Pharmaceutical Inc from 2010 to 2025, covering 16 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read total liabilities of Biomarin Pharmaceutical Inc for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 6.5% | $492.24 Million | $7.59 Billion | ▼ -1.0 pp |
| 2024 | 7.5% | $521.24 Million | $6.99 Billion | ▼ -1.5 pp |
| 2023 | 8.9% | $611.13 Million | $6.84 Billion | ▲ +3.7 pp |
| 2022 | 5.2% | $333.83 Million | $6.38 Billion | ▼ -3.2 pp |
| 2021 | 8.5% | $507.79 Million | $6.00 Billion | ▲ +3.6 pp |
| 2020 | 4.9% | $285.47 Million | $5.85 Billion | ▼ -3.9 pp |
| 2019 | 8.8% | $411.98 Million | $4.69 Billion | ▲ +3.5 pp |
| 2018 | 5.3% | $235.86 Million | $4.43 Billion | ▼ -3.0 pp |
| 2017 | 8.3% | $385.79 Million | $4.63 Billion | ▼ -5.9 pp |
| 2016 | 14.2% | $572.71 Million | $4.02 Billion | ▲ +2.3 pp |
| 2015 | 11.9% | $443.71 Million | $3.73 Billion | ▲ +7.9 pp |
| 2014 | 4.0% | $98.89 Million | $2.49 Billion | ▼ -8.0 pp |
| 2013 | 12.0% | $268.52 Million | $2.24 Billion | ▲ +4.5 pp |
| 2012 | 7.5% | $117.07 Million | $1.57 Billion | ▲ +0.2 pp |
| 2011 | 7.3% | $94.94 Million | $1.31 Billion | ▼ -3.0 pp |
| 2010 | 10.2% | $129.25 Million | $1.26 Billion | — |